Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

AstraZeneca
Pharmaceuticals
GSK
Novartis
Johnson and Johnson
Sanofi
Pfizer
Topics

Advertisement

Advertisement

AstraZeneca

Share

Top Latest Popular

Yesterday

Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval Proactive Investors (US) 15:05 Mon, 07 Sep

AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah Zacks 14:51 Mon, 07 Sep

FDA overrides adcomm and approves AZ's oral SERD pharmaphorum 11:25 Mon, 07 Sep

Advertisement

Advertisement

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer Hospital Management 10:18 Mon, 07 Sep

AstraZeneca's breast cancer drug granted accelerated approval in the US ShareCast 09:04 Mon, 07 Sep

AstraZeneca's breast cancer drug gets accelerated US approval, Spire Healthcare agrees to £1.03bn takeover bid ShareCast 07:53 Mon, 07 Sep

Saturday

Etcamah® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer Business Wire (Press Release) 00:04 Sat, 05 Sep

Friday

Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s Etcamah™ (camizestrant) in Advanced Breast Cancer Business Wire (Press Release) 23:14 Fri, 04 Sep

AstraZeneca’s Etcamah Gets Long-Awaited FDA Breast Cancer Approval Scrip Pharma Intelligence 22:58 Fri, 04 Sep

AstraZeneca’s Breast Cancer Pill Gets Approval From the FDA Bloomberg Law 22:27 Fri, 04 Sep

Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer AstraZeneca (Press Release) 21:40 Fri, 04 Sep

Thursday

The Zacks Analyst Blog Highlights AMD, Costco, AstraZeneca, Peoples Bancorp of North Carolina and Spruce Power Zacks 15:02 Thu, 03 Sep

Boehringer signs AI drug discovery deal with Owkin pharmaphorum 10:20 Thu, 03 Sep

Wednesday

Top Stock Reports for AMD, Costco & AstraZeneca Zacks 22:44 Wed, 02 Sep

The science behind an ambitious cancer strategy New Scientist 18:07 Wed, 02 Sep

Advertisement

In the last month

Enhertu OK ends 10-year EU gap in frontline breast cancer pharmaphorum 22:10 Tue, 01 Sep

What Does AstraZeneca (LSE:AZN) News Mean For Its Cancer And Pipeline Growth? Simply Wall St 21:23 Tue, 01 Sep

ESC 2026: AstraZeneca’s oral relaxin agonist succeeds in Phase II trial Clinical Trials Arena 17:48 Tue, 01 Sep

Success For AstraZeneca And Hutchmed’s Oral Combo In First Line NSCLC Scrip Pharma Intelligence 16:40 Tue, 01 Sep

AstraZeneca Shares Dual Oncology Clinical and Regulatory Victories Benzinga 13:04 Tue, 01 Sep

AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab approved in EU as first-line treatment for breast cancer PMLiVE 12:54 Tue, 01 Sep

AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy® (sunvozertinib) for lung cancer Business Wire (Press Release) 12:02 Tue, 01 Sep

AstraZeneca And Daiichi Sankyo Gain EU Nod For Enhertu Plus Pertuzumab In HER2+ Breast Cancer RTT News 11:00 Tue, 01 Sep

Astrazeneca Seals Licence Agreement With Dizal Pharma For Lung Cancer Drug Zegfrovy Outlook Business 10:17 Tue, 01 Sep

AstraZeneca lifts lung‑cancer pipeline with Zegfrovy deal, Tagrisso data ShareCast 08:40 Tue, 01 Sep

AstraZeneca delivers dual lung‑cancer updates, Veritas snaps up Bodycote for £1.64bn ShareCast 07:48 Tue, 01 Sep

Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer Business Wire (Press Release) 07:37 Tue, 01 Sep

Enhertu plus pertuzumab approved in the EU as first new regimen in more than a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer AstraZeneca (Press Release) 07:37 Tue, 01 Sep

AstraZeneca Reports Positive Results Of Sanovo Phase III Trial In China RTT News 07:37 Tue, 01 Sep

AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer AstraZeneca (Press Release) 07:16 Tue, 01 Sep

Judge Rejects AstraZeneca's Attack On Colo. 340B Law Law360 00:11 Tue, 01 Sep

AstraZeneca Loses Suit Seeking Block on Colorado Pharmacy Law Bloomberg Law 22:49 Mon, 31 Aug

AstraZeneca’s Bob Li on the MARS mission to eliminate cancer The McKinsey Quarterly 17:34 Mon, 31 Aug

ESC26: AZ's relaxin agonist shows promise in heart failure pharmaphorum 15:49 Mon, 31 Aug

ESC: Wainua Data From AstraZeneca/Ionis Undercut ATTR-CM Combo Case Scrip Pharma Intelligence 10:14 Mon, 31 Aug

STAT Plus: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua STAT 18:33 Sun, 30 Aug

Tezspire Crossing to EoE? Astrazeneca, Amgen say phase III a win BioWorld 21:29 Fri, 28 Aug

STAT Plus: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more STAT 14:51 Fri, 28 Aug

STAT Plus: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching STAT 14:41 Fri, 28 Aug

STAT Plus: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs STAT 10:35 Fri, 28 Aug

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis